EcoDrugPlus

Leukotriene A-4 Hydrolase-Like

Ensembl ID : ENSSTUG00000049777
Gene Symbol: LOC115180638
3 Cross references
198 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSSTUG00000001440
Gene Symbol: LTB4R
3 Cross references
79 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSTUG00000007218
Gene Symbol: LOC115157292
3 Cross references
161 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSTUG00000022794
Gene Symbol: LOC115194511
2 Cross references
151 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSSTUG00000013501
Gene Symbol: LOC115169506
3 Cross references
161 Possible Orthologues:

Leukotriene B4 Receptor 2-Like

Ensembl ID : ENSSTUG00000001445
Gene Symbol: LOC115198477
2 Cross references
151 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSSTUG00000033687
Gene Symbol: LOC115201179
3 Cross references
200 Possible Orthologues:

Lysine-Specific Histone Demethylase 1a-Like

Ensembl ID : ENSSTUG00000015929
Gene Symbol: LOC115172875
3 Cross references
205 Possible Orthologues:

Lysine-Specific Histone Demethylase 1a-Like

Ensembl ID : ENSSTUG00000021479
Gene Symbol: LOC115162572
3 Cross references
207 Possible Orthologues:

Lysosomal Acid Glucosylceramidase-Like

Ensembl ID : ENSSTUG00000040763
Gene Symbol: LOC115176398
2 Cross references
244 Possible Orthologues:

Lysosomal Acid Glucosylceramidase-Like

Ensembl ID : ENSSTUG00000038761
Gene Symbol: LOC115177217
2 Cross references
246 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSSTUG00000004916
Gene Symbol: LOC115208038
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).